China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) announced that it has obtained medical device approval from the National Medical Products Administration (NMPA) for its pertussis nucleic acid detection kit (PCR fluorescence probe method).
Product and Application
The product, used for the auxiliary diagnosis of patients with respiratory tract infection and suspected pertussis bacilli infection, covers pediatrics, respiratory, infection, and other application scenarios.-Fineline Info & Tech
